Literature DB >> 25797427

Ultrasound-based therapies not mentioned.

Milka Marinova, Maximilian Rauch, Holger Strunk.   

Abstract

Mesh：

Year:  2015        PMID： 25797427      PMCID： PMC4335494          DOI： 10.3238/arztebl.2015.0060a

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

Review 1.  Ductal pancreatic adenocarcinoma.

Authors:  Thomas Seufferlein; Marc Porzner; Volker Heinemann; Andrea Tannapfel; Martin Stuschke; Waldemar Uhl
Journal:  Dtsch Arztebl Int       Date:  2014-05-30       Impact factor: 5.594

2.  The current potential of high-intensity focused ultrasound for pancreatic carcinoma.

Authors:  Atsushi Sofuni; Fuminori Moriyasu; Takatomo Sano; Kota Yamada; Fumihide Itokawa; Takayoshi Tsuchiya; Shujiro Tsuji; Toshio Kurihara; Kentaro Ishii; Takao Itoi
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-05       Impact factor: 7.027

3.  Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer.

Authors:  Hong Zhao; Guowang Yang; Daoyuan Wang; Xiangrong Yu; Yu Zhang; Junqiu Zhu; Yongle Ji; Baoliang Zhong; Wenshuo Zhao; Zhong Yang; Fahad Aziz
Journal:  Anticancer Drugs       Date:  2010-04       Impact factor: 2.248

4.  High intensity focused ultrasound treatment for patients with local advanced pancreatic cancer.

Authors:  Hui-Feng Gao; Kun Wang; Zhi-Qiang Meng; Zhen Chen; Jun-Hua Lin; Zhen-Hua Zhou; Peng Wang; Wei-Dong Shi; Ye-Hua Sheng
Journal:  Hepatogastroenterology       Date:  2013 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.